Enrichment Strategy for Systemic Sclerosis Clinical Trials Targeting Skin Fibrosis: A Prospective, Multiethnic Cohort Study.

We demonstrated in an ethnically diverse cohort of patients with early dcSSc and with a high proportion of patients who are Pol3-positive that setting an upper limit of the mRSS as a selection criterion leads effectively to cohort enrichment with progressors.